Spect Scans 2
This series of scans belong to a 36 year old female that has taken amphetamine sulfate (Adderall) and 150 mg. of Effexor for over 5 years for Attention Deficit Disorder (ADD).
This SPECT scan shows the typical prefrontal cortex of an ADD patient who is concentrating without any medication. It clearly shows the deep pockets where the brain has essentially gone to sleep and is unable to focus.
This second scan is the same brain and the same concentration task with two capsules of the supplement ADD-care®. Lobe on the left of the image is almost completely smooth. The lobe on the right side of the image has improved by 40-50%, and the whole brain is smoother and fuller.
The third scan is with 20 mg. of the amphetamine during concentration. The left lobe is not quite as good as the ADD-care scan, but the right lobe is about 40% better. The supplement performed at roughly 75% to 85% as well as the popular stimulant for prefrontal activity.
This is the deep view of the same patient's scans. This first scan is the same concentration scan without medication. The white areas show any part of the brain that is working 15% greater than it should optimally. However the bottom part of the brain or cerebellum is different and should be completely filled in with white suggesting dopamine activity.
The two large white areas on either side of center are the basal ganglia. The middle section is the limbic system. The cingulate system often appears like a Mohawk haircut running up and down the full length of the middle of the brain. At the top of the limbic system the small white area indicates that the cingulate system is also over-activated.
This is the ADD-care® supplement scan and it clearly shows that there is much improvement in the cerebellum. With ADD-care the basal ganglia and cingulate system have cleared dramatically and the limbic system has been reduced by at least 85-90%. This is why people feel calm as well as focused on the ADD-care® supplement.
This scan is with amphetamine sulfate (Adderall). It has 85-90% of cerebellum activity compared to the supplement. The basal ganglia, limbic, and cingulate system though are still quite pronounced and that can cause a lot of the side effects that people see with the stimulants. The ADD-care® supplement performed 100% better on the internal scans.
During each scan the Conner's ADD-impulsivity test was administered. During the first scan the patient missed 15.11, in the second scan she missed 4.51, and in the third scan the patient missed 10.67 so ADD-care®'s performance surpassed amphetamine sulfate (Adderall) significantly.

